In trading on Wednesday, shares of Nektar Therapeutics (NKTR - Get Report) crossed below their 200 day moving average of $9.06, changing hands as low as $9.05 per share. Nektar Therapeutics shares are currently trading down about 5% on the day. The chart below shows the one year performance of NKTR shares, versus its 200 day moving average:Looking at the chart above, NKTR's low point in its 52 week range is $5.65 per share, with $11.34 as the 52 week high point — that compares with a last trade of $9.24. According to the ETF Finder at ETF Channel, NKTR makes up 1.33% of the SPDR S&P Pharmaceuticals ETF ( XPH) which is trading lower by about 0.2% on the day Wednesday.
More from Stocks
Should Investors Be Optimistic About U.S.-China Trade Talks?
Need some advice when it comes to U.S.-China trade talks?
Tailored Brands' Dividend Disappears -- Try On This Alternative Dividend Stock
Hanesbrands is one consumer cyclical offering a 3.8% dividend yield.
Biometric Passwords Are About to Go Big Time; Here's Who's Set to Profit
Diebold Nixdorf is best known for its 35% global market share of automated teller machines, but it is successfully branching out into digital verification.
Avoid the 'Lunacy' of After-Hours Trading, Jim Cramer Says
Jim says after-hours action can be 'crazy' -- just look at what happened when Palo Alto Networks reported earnings.